Literature DB >> 21097551

Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients.

B Marin1, J C Desport, P Kajeu, P Jesus, B Nicolaud, M Nicol, P M Preux, P Couratier.   

Abstract

OBJECTIVES: The aims were to analyse changes in nutritional parameters from diagnosis of amyotrophic lateral sclerosis (ALS) to death and to assess their relationships with survival at the time of diagnosis and during follow-up.
METHODS: 92 ALS patients were included and clinically assessed every 3 months (ALS functional rating scale, manual muscular testing, forced vital capacity, weight, BMI, percentage weight loss). Bioimpedance was performed to evaluate body composition (fat-free mass, fat mass and hydration status) and phase angle. Survival analyses were performed from diagnosis to death or censoring date using a Cox model.
RESULTS: The evolution of nutritional parameters in ALS patients was marked by significant decreases in weight, BMI, fat-free mass and phase angle, and increased fat mass. The authors identified an adjusted 30% increased risk of death for a 5% decrease from usual weight at time of diagnosis (RR 1.30; 95% CI 1.08 to 1.56). During follow-up, the authors identified adjusted 34% (95% CI 18% to 51%) and 24% (95% CI 13% to 36%) increased risks of death associated with each 5% decrease in usual weight and each unit decrease in usual BMI, respectively (p<0.0001). Malnutrition during the course was related to a shorter survival (p=0.01), and fat mass level was associated with a better outcome (RR 0.90 for each 2.5 kg fat mass increment).
CONCLUSIONS: Nutritional parameters of ALS patients worsened during evolution of the disease, and worse nutritional status (at time of diagnosis or during the course) was associated with a higher mortality. This study offers some justification for studying the use of therapeutic nutritional intervention to modify the survival of ALS patients.

Entities:  

Mesh:

Year:  2010        PMID: 21097551     DOI: 10.1136/jnnp.2010.211474

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  57 in total

Review 1.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans.

Authors:  Daniela Mariosa; John D Beard; David M Umbach; Rino Bellocco; Jean Keller; Tracy L Peters; Kelli D Allen; Weimin Ye; Dale P Sandler; Silke Schmidt; Fang Fang; Freya Kamel
Journal:  Am J Epidemiol       Date:  2017-03-01       Impact factor: 4.897

Review 3.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

4.  Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.

Authors:  Johannes Dorst; Luc Dupuis; Susanne Petri; Katja Kollewe; Susanne Abdulla; Joachim Wolf; Markus Weber; David Czell; Christian Burkhardt; Frank Hanisch; Stefan Vielhaber; Thomas Meyer; Gabriele Frisch; Dagmar Kettemann; Torsten Grehl; Bertold Schrank; Albert C Ludolph
Journal:  J Neurol       Date:  2015-01-25       Impact factor: 4.849

5.  Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study.

Authors:  Marianthi-Anna Kioumourtzoglou; Ran S Rotem; Ryan M Seals; Ole Gredal; Johnni Hansen; Marc G Weisskopf
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

Review 6.  Measurement of body composition as a surrogate evaluation of energy balance in obese patients.

Authors:  Carlo Maria Rotella; Ilaria Dicembrini
Journal:  World J Methodol       Date:  2015-03-26

Review 7.  Supportive and symptomatic management of amyotrophic lateral sclerosis.

Authors:  Esther V Hobson; Christopher J McDermott
Journal:  Nat Rev Neurol       Date:  2016-08-12       Impact factor: 42.937

Review 8.  ALS: Management Problems.

Authors:  Jonathan R Brent; Colin K Franz; John M Coleman; Senda Ajroud-Driss
Journal:  Neurol Clin       Date:  2020-06-11       Impact factor: 3.806

9.  An exploratory study of serum creatinine levels in patients with amyotrophic lateral sclerosis.

Authors:  Xueping Chen; Xiaoyan Guo; Rui Huang; Zhenzhen Zheng; Yongping Chen; Hui-Fang Shang
Journal:  Neurol Sci       Date:  2014-04-30       Impact factor: 3.307

10.  Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status.

Authors:  Christian Lunetta; Andrea Lizio; Lucio Tremolizzo; Massimiliano Ruscica; Chiara Macchi; Nilo Riva; Patrick Weydt; Ettore Corradi; Paolo Magni; Valeria Sansone
Journal:  J Neurol       Date:  2018-10-22       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.